VANCOMYCIN HYDROCHLORIDE

VANCOMYCIN HYDROCHLORIDE was reported 8358 times

VANCOMYCIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VANCOMYCIN INFUSION REACTION 300 0.7958
1 RED MAN SYNDROME 438 0.4977
2 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 170 0.4187
3 LINEAR IGA DISEASE 679 0.4078
4 GEOTRICHUM INFECTION 64 0.3033
5 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 82 0.2654
6 CHOROIDITIS 90 0.2406
7 TRICHOSPORON INFECTION 60 0.1481
8 RETINAL VASCULITIS 171 0.1436
9 DISSEMINATED MUCORMYCOSIS 54 0.1371
10 RHINOCEREBRAL MUCORMYCOSIS 46 0.1326
11 ENTEROCOCCUS TEST POSITIVE 79 0.1219
12 CARDIAC VALVE VEGETATION 56 0.1152
13 BACTERIAL DISEASE CARRIER 81 0.1111
14 FUNGAEMIA 174 0.1105
15 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2724 0.1058
16 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 40 0.1053
17 ACINETOBACTER INFECTION 112 0.1023
18 CONGESTIVE HEPATOPATHY 45 0.1004
19 DYSBIOSIS 82 0.0999
20 SEPTIC EMBOLUS 80 0.0962
21 SYSTEMIC CANDIDA 236 0.0939
22 STENOTROPHOMONAS INFECTION 126 0.0929
23 RENAL TUBULAR NECROSIS 904 0.0921
24 ENTEROCOCCAL INFECTION 425 0.0879
25 PSEUDOMEMBRANOUS COLITIS 194 0.0868
26 RASH MORBILLIFORM 231 0.0832
27 NEPHROPATHY TOXIC 931 0.0829
28 CLOSTRIDIUM TEST POSITIVE 181 0.0820
29 PSEUDOMONAL BACTERAEMIA 70 0.0820
30 SEPSIS SYNDROME 41 0.0817
31 FUSARIUM INFECTION 56 0.0800
32 STAPHYLOCOCCAL BACTERAEMIA 332 0.0763
33 CORYNEBACTERIUM INFECTION 39 0.0729
34 ENTEROCOCCAL SEPSIS 59 0.0728
35 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 233 0.0717
36 ENTEROCOCCAL BACTERAEMIA 75 0.0708
37 CLOSTRIDIUM DIFFICILE COLITIS 741 0.0698
38 CLOSTRIDIUM DIFFICILE INFECTION 1510 0.0691
39 PNEUMONIA NECROTISING 44 0.0680
40 MEGACOLON 105 0.0668
41 CRYSTAL NEPHROPATHY 39 0.0659
42 DEVICE RELATED SEPSIS 132 0.0655
43 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 509 0.0655
44 BRONCHIAL SECRETION RETENTION 83 0.0651
45 OTOTOXICITY 119 0.0643
46 EOSINOPHILIC PNEUMONIA ACUTE 54 0.0624
47 BACILLUS INFECTION 39 0.0617
48 SUPERINFECTION 92 0.0613
49 FUNGAL SEPSIS 50 0.0602
50 PATHOGEN RESISTANCE 546 0.0598
51 MUCORMYCOSIS 151 0.0581
52 NEPHRITIS INTERSTITIAL 73 0.0577
53 CLOSTRIDIUM COLITIS 70 0.0577
54 TOXIC ANTERIOR SEGMENT SYNDROME 62 0.0568
55 RETINAL VASCULAR OCCLUSION 42 0.0568
56 TOXIC EPIDERMAL NECROLYSIS 861 0.0566
57 APLASTIC ANAEMIA 296 0.0566
58 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 46 0.0560
59 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 59 0.0556
60 EOSINOPHILIA 958 0.0546
61 KLEBSIELLA INFECTION 275 0.0543
62 KOUNIS SYNDROME 120 0.0528
63 PROCALCITONIN INCREASED 61 0.0520
64 ENDOCARDITIS 264 0.0514
65 DIFFUSE ALVEOLAR DAMAGE 59 0.0513
66 CANDIDA SEPSIS 46 0.0513
67 RENAL TUBULAR INJURY 62 0.0510
68 ENDOCARDITIS BACTERIAL 40 0.0508
69 PNEUMONIA STAPHYLOCOCCAL 98 0.0496
70 HISTIOCYTOSIS HAEMATOPHAGIC 147 0.0495
71 SYSTEMIC MYCOSIS 56 0.0479
72 STAPHYLOCOCCUS TEST POSITIVE 101 0.0479
73 TYPE IV HYPERSENSITIVITY REACTION 129 0.0470
74 CONTINUOUS HAEMODIAFILTRATION 46 0.0470
75 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1299 0.0458
76 MULTI-ORGAN FAILURE 792 0.0458
77 BRAIN ABSCESS 115 0.0454
78 BLOOD CULTURE POSITIVE 136 0.0454
79 ENTEROBACTER INFECTION 76 0.0452
80 STAPHYLOCOCCAL SEPSIS 221 0.0447
81 TUBULOINTERSTITIAL NEPHRITIS 836 0.0446
82 ASPERGILLOSIS 57 0.0436
83 ENDOPHTHALMITIS 261 0.0435
84 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 165 0.0431
85 BACTERAEMIA 510 0.0429
86 HYPOPERFUSION 45 0.0428
87 MENINGITIS BACTERIAL 61 0.0426
88 SEPTIC SHOCK 1851 0.0425
89 NEPHROGENIC ANAEMIA 196 0.0423
90 MULTIPLE-DRUG RESISTANCE 130 0.0419
91 VASCULAR DEVICE INFECTION 188 0.0414
92 INTERVERTEBRAL DISCITIS 78 0.0413
93 HAEMODYNAMIC INSTABILITY 315 0.0413
94 PNEUMONIA KLEBSIELLA 75 0.0408
95 STREPTOCOCCAL BACTERAEMIA 44 0.0404
96 STRONGYLOIDIASIS 65 0.0402
97 RASH MACULO-PAPULAR 835 0.0375
98 DRUG LEVEL INCREASED 618 0.0373
99 KLEBSIELLA SEPSIS 42 0.0373
100 PSEUDOMONAS INFECTION 315 0.0367
101 OLIGURIA 228 0.0367
102 ASPERGILLUS INFECTION 241 0.0367
103 CLOSTRIDIAL INFECTION 124 0.0366
104 PERIPHERAL SENSORIMOTOR NEUROPATHY 46 0.0366
105 DISSEMINATED INTRAVASCULAR COAGULATION 513 0.0364
106 BRONCHOPULMONARY ASPERGILLOSIS 282 0.0363
107 APLASIA 71 0.0362
108 VENOOCCLUSIVE LIVER DISEASE 177 0.0358
109 NEUTROPENIC COLITIS 74 0.0357
110 EOSINOPHILIC PNEUMONIA 112 0.0355
111 NECROTISING COLITIS 45 0.0355
112 HUMAN HERPESVIRUS 6 INFECTION 67 0.0354
113 DRUG LEVEL ABOVE THERAPEUTIC 161 0.0351
114 HYPERPARATHYROIDISM SECONDARY 88 0.0351
115 NECROTISING FASCIITIS 122 0.0346
116 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 259 0.0345
117 BACTERIAL SEPSIS 111 0.0340
118 PNEUMONIA FUNGAL 134 0.0339
119 EMPYEMA 66 0.0332
120 HISTOPLASMOSIS DISSEMINATED 52 0.0327
121 RENAL TUBULAR DISORDER 92 0.0327
122 ACUTE KIDNEY INJURY 4987 0.0326
123 IMMUNE THROMBOCYTOPENIA 147 0.0321
124 PSEUDOMONAL SEPSIS 56 0.0319
125 LIVER ABSCESS 102 0.0314
126 DRUG CLEARANCE DECREASED 41 0.0314
127 ACUTE RESPIRATORY DISTRESS SYNDROME 548 0.0310
128 ATELECTASIS 299 0.0309
129 CUTANEOUS VASCULITIS 112 0.0307
130 STAPHYLOCOCCAL INFECTION 1009 0.0306
131 DIABETES INSIPIDUS 73 0.0303
132 DERMATITIS EXFOLIATIVE GENERALISED 105 0.0302
133 DRUG RESISTANCE 771 0.0300
134 CULTURE URINE POSITIVE 42 0.0299
135 HENOCH-SCHONLEIN PURPURA 65 0.0297
136 HAEMODIALYSIS 249 0.0296
137 FUNGAL PERITONITIS 45 0.0296
138 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 63 0.0296
139 CRYPTOCOCCOSIS 48 0.0294
140 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 78 0.0293
141 GRAFT VERSUS HOST DISEASE 209 0.0290
142 HYPERNATRAEMIA 144 0.0289
143 DERMATITIS EXFOLIATIVE 143 0.0285
144 LEUKOCYTOSIS 516 0.0285
145 WOUND INFECTION STAPHYLOCOCCAL 49 0.0283
146 HEPARIN-INDUCED THROMBOCYTOPENIA 139 0.0282
147 HYPOALBUMINAEMIA 219 0.0281
148 RENAL FAILURE ACUTE 1192 0.0281
149 HEPATOSPLENOMEGALY 72 0.0280
150 TOXIC SKIN ERUPTION 280 0.0278
151 METABOLIC ENCEPHALOPATHY 83 0.0276
152 ESCHERICHIA BACTERAEMIA 65 0.0276
153 ADENOVIRUS INFECTION 80 0.0276
154 PULSELESS ELECTRICAL ACTIVITY 115 0.0275
155 NOCARDIOSIS 70 0.0273
156 INFECTIOUS PLEURAL EFFUSION 41 0.0269
157 CANDIDA INFECTION 454 0.0269
158 VENOOCCLUSIVE DISEASE 67 0.0267
159 DEVICE RELATED INFECTION 406 0.0263
160 GRAFT VERSUS HOST DISEASE IN SKIN 58 0.0263
161 PNEUMOMEDIASTINUM 47 0.0260
162 HAEMOTHORAX 75 0.0258
163 ACUTE RESPIRATORY FAILURE 495 0.0257
164 STEVENS-JOHNSON SYNDROME 565 0.0254
165 SKIN NECROSIS 131 0.0252
166 DRUG ERUPTION 446 0.0251
167 ENCEPHALOPATHY 616 0.0251
168 ESCHERICHIA INFECTION 204 0.0248
169 NOSOCOMIAL INFECTION 54 0.0245
170 BRAIN HERNIATION 73 0.0244
171 AUTOIMMUNE HAEMOLYTIC ANAEMIA 83 0.0242
172 LUNG CONSOLIDATION 67 0.0239
173 DERMATITIS BULLOUS 172 0.0237
174 TOXIC ENCEPHALOPATHY 120 0.0237
175 ARTHRITIS BACTERIAL 97 0.0236
176 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 65 0.0235
177 ANURIA 202 0.0234
178 ACIDOSIS 179 0.0234
179 FIBROSIS 72 0.0234
180 SHOCK 536 0.0233
181 FEBRILE BONE MARROW APLASIA 99 0.0233
182 CAPILLARY LEAK SYNDROME 48 0.0232
183 METHAEMOGLOBINAEMIA 53 0.0229
184 HYPERSENSITIVITY VASCULITIS 60 0.0228
185 RENAL INJURY 676 0.0227
186 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 75 0.0227
187 RESPIRATORY ACIDOSIS 87 0.0221
188 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 110 0.0221
189 RESPIRATORY FAILURE 1606 0.0220
190 BACTERIAL TEST POSITIVE 49 0.0220
191 ABSCESS LIMB 93 0.0218
192 DRUG LEVEL BELOW THERAPEUTIC 120 0.0217
193 LUNG INFILTRATION 192 0.0217
194 SEPSIS 2412 0.0216
195 PROTHROMBIN TIME PROLONGED 128 0.0214
196 FEBRILE NEUTROPENIA 1416 0.0213
197 END STAGE RENAL DISEASE 386 0.0211
198 CHOLESTATIC LIVER INJURY 47 0.0211
199 PULMONARY HAEMORRHAGE 164 0.0209
200 HYPOXIA 737 0.0209
201 INTRAVENTRICULAR HAEMORRHAGE 52 0.0209
202 PANCYTOPENIA 1164 0.0208
203 INFLAMMATORY MARKER INCREASED 103 0.0208
204 COMPLICATIONS OF TRANSPLANTED KIDNEY 47 0.0207
205 GLOMERULONEPHRITIS 50 0.0204
206 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 102 0.0201
207 WOUND DEHISCENCE 68 0.0201
208 HYPERCAPNIA 60 0.0199
209 AGRANULOCYTOSIS 368 0.0198
210 HYPERBILIRUBINAEMIA 205 0.0198
211 LIVEDO RETICULARIS 41 0.0196
212 ORGAN FAILURE 79 0.0196
213 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 116 0.0196
214 CYTOMEGALOVIRUS COLITIS 45 0.0195
215 AZOTAEMIA 78 0.0195
216 PURPURA 172 0.0194
217 DISTRIBUTIVE SHOCK 44 0.0194
218 GENERALISED OEDEMA 238 0.0192
219 HYPERAMMONAEMIA 96 0.0192
220 ACUTE MYELOID LEUKAEMIA RECURRENT 41 0.0191
221 LUNG ABSCESS 40 0.0190
222 CYTOLYTIC HEPATITIS 63 0.0190
223 CANDIDIASIS 76 0.0189
224 SHOCK HAEMORRHAGIC 154 0.0189
225 COAGULOPATHY 314 0.0188
226 TACHYPNOEA 255 0.0187
227 RENAL FAILURE 2487 0.0187
228 MENTAL STATUS CHANGES 518 0.0186
229 HYPOVOLAEMIA 109 0.0186
230 MENINGITIS 124 0.0185
231 ENDOTRACHEAL INTUBATION 52 0.0185
232 RENAL IMPAIRMENT 1555 0.0185
233 ANHEDONIA 485 0.0184
234 CYTOMEGALOVIRUS VIRAEMIA 82 0.0184
235 IMMUNE THROMBOCYTOPENIC PURPURA 52 0.0184
236 BLOOD CREATININE INCREASED 1199 0.0183
237 ACUTE GRAFT VERSUS HOST DISEASE 84 0.0183
238 EXFOLIATIVE RASH 48 0.0182
239 OSTEOMYELITIS 330 0.0182
240 FEAR 487 0.0181
241 HYPERTHERMIA 138 0.0181
242 NECROSIS 100 0.0179
243 PERIPHERAL ISCHAEMIA 72 0.0176
244 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 41 0.0176
245 SINUS OPERATION 42 0.0176
246 NEUROTOXICITY 308 0.0176
247 PNEUMONIA BACTERIAL 161 0.0175
248 REBOUND ACID HYPERSECRETION 53 0.0175
249 STREPTOCOCCAL INFECTION 97 0.0174
250 RESPIRATORY DISTRESS 479 0.0173
251 CHOLESTASIS 333 0.0173
252 ERYTHEMA MULTIFORME 161 0.0172
253 AORTIC ARTERIOSCLEROSIS 44 0.0171
254 MIXED LIVER INJURY 51 0.0169
255 NEPHROPATHY 158 0.0169
256 CYTOMEGALOVIRUS INFECTION 281 0.0169
257 METABOLIC ACIDOSIS 539 0.0168
258 CYTOKINE RELEASE SYNDROME 333 0.0166
259 CYTOMEGALOVIRUS INFECTION REACTIVATION 73 0.0165
260 SERUM FERRITIN INCREASED 87 0.0165
261 PNEUMATOSIS INTESTINALIS 47 0.0165
262 NEPHRITIS 55 0.0165
263 DIALYSIS 232 0.0163
264 TORSADE DE POINTES 128 0.0163
265 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 155 0.0162
266 ESCHERICHIA SEPSIS 47 0.0162
267 VENTRICULAR HYPOKINESIA 52 0.0162
268 THROMBOTIC THROMBOCYTOPENIC PURPURA 57 0.0162
269 JAUNDICE CHOLESTATIC 57 0.0161
270 BLOOD ALBUMIN DECREASED 128 0.0161
271 BLOOD UREA INCREASED 269 0.0160
272 DRUG-INDUCED LIVER INJURY 503 0.0160
273 RENAL FAILURE CHRONIC 123 0.0160
274 INCORRECT DRUG ADMINISTRATION RATE 68 0.0160
275 EOSINOPHIL COUNT INCREASED 133 0.0159
276 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 875 0.0159
277 THROMBOTIC MICROANGIOPATHY 155 0.0159
278 ENCEPHALITIS 110 0.0159
279 BRAIN DEATH 49 0.0158
280 PULSE ABSENT 75 0.0158
281 THROMBOCYTOPENIA 1759 0.0157
282 ABSCESS 250 0.0157
283 ABDOMINAL INFECTION 40 0.0156
284 HEPATOMEGALY 153 0.0156
285 NEPHROGENIC SYSTEMIC FIBROSIS 47 0.0155
286 LEUKOPENIA 776 0.0155
287 SCOLIOSIS 96 0.0155
288 CYSTITIS HAEMORRHAGIC 62 0.0154
289 TRANSAMINASES INCREASED 342 0.0154
290 MUCOSAL INFLAMMATION 401 0.0153
291 URINE OUTPUT DECREASED 133 0.0152
292 FACE OEDEMA 256 0.0152
293 BLOOD BILIRUBIN INCREASED 406 0.0150
294 ENTEROCOLITIS 85 0.0147
295 STATUS EPILEPTICUS 165 0.0146
296 MALNUTRITION 163 0.0146
297 NEUTROPENIC SEPSIS 104 0.0145
298 HYPOKALAEMIA 671 0.0145
299 HAEMOLYTIC ANAEMIA 130 0.0145
300 PLEURAL EFFUSION 878 0.0144
301 HYPERVOLAEMIA 71 0.0144
302 INTESTINAL ISCHAEMIA 79 0.0143
303 BACTERIAL INFECTION 266 0.0142
304 PETECHIAE 148 0.0142
305 SINUS TACHYCARDIA 201 0.0141
306 FAILURE TO THRIVE 73 0.0140
307 BLOOD CREATINE INCREASED 62 0.0140
308 DECUBITUS ULCER 114 0.0140
309 CACHEXIA 71 0.0138
310 BONE MARROW FAILURE 280 0.0138
311 HYDROCEPHALUS 75 0.0138
312 PULMONARY ALVEOLAR HAEMORRHAGE 77 0.0137
313 HEPATOCELLULAR INJURY 194 0.0137
314 BLOOD LACTATE DEHYDROGENASE INCREASED 216 0.0136
315 PNEUMOTHORAX 215 0.0135
316 TUMOUR LYSIS SYNDROME 118 0.0134
317 BLOOD ALKALINE PHOSPHATASE INCREASED 331 0.0133
318 HEPATIC NECROSIS 50 0.0133
319 BRONCHOSPASM 189 0.0132
320 CREATININE RENAL CLEARANCE DECREASED 53 0.0132
321 AORTIC VALVE INCOMPETENCE 56 0.0131
322 BLOOD LACTIC ACID INCREASED 69 0.0131
323 C-REACTIVE PROTEIN INCREASED 472 0.0130
324 ABDOMINAL ABSCESS 57 0.0129
325 EXTRAVASATION 53 0.0129
326 PNEUMONIA VIRAL 41 0.0128
327 ELECTROLYTE IMBALANCE 149 0.0128
328 SEROTONIN SYNDROME 246 0.0128
329 DEAFNESS NEUROSENSORY 42 0.0128
330 HYPOPHOSPHATAEMIA 94 0.0127
331 VENTRICULAR TACHYCARDIA 210 0.0127
332 CATHETER SITE INFECTION 48 0.0127
333 HAEMOLYSIS 98 0.0127
334 PURULENT DISCHARGE 54 0.0126
335 HYPERTRIGLYCERIDAEMIA 74 0.0126
336 CELLULITIS 636 0.0126
337 EPSTEIN-BARR VIRUS INFECTION 78 0.0125
338 ASCITES 366 0.0124
339 HEPATITIS CHOLESTATIC 75 0.0124
340 RASH PUSTULAR 90 0.0123
341 HYPERPYREXIA 52 0.0123
342 DRUG LEVEL DECREASED 125 0.0123
343 ADRENAL INSUFFICIENCY 148 0.0122
344 HYPOMAGNESAEMIA 169 0.0121
345 ILEUS PARALYTIC 54 0.0121
346 FLUID OVERLOAD 176 0.0121
347 MYOCLONUS 144 0.0121
348 ANAL ABSCESS 65 0.0120
349 CARDIOGENIC SHOCK 173 0.0120
350 ISCHAEMIA 55 0.0120
351 GAMMA-GLUTAMYLTRANSFERASE INCREASED 265 0.0119
352 ANAPHYLACTIC REACTION 659 0.0119
353 PYREXIA 4117 0.0119
354 BK VIRUS INFECTION 40 0.0118
355 HEPATIC FUNCTION ABNORMAL 441 0.0118
356 ALANINE AMINOTRANSFERASE INCREASED 725 0.0118
357 HYPERTRANSAMINASAEMIA 82 0.0118
358 HEPATIC FAILURE 354 0.0117
359 HERPES SIMPLEX 76 0.0117
360 HYPERURICAEMIA 48 0.0117
361 ANAPHYLACTOID REACTION 48 0.0117
362 PNEUMOCYSTIS JIROVECII PNEUMONIA 117 0.0116
363 BRAIN OEDEMA 147 0.0116
364 ACUTE HEPATIC FAILURE 159 0.0116
365 MITRAL VALVE INCOMPETENCE 131 0.0116
366 CIRCULATORY COLLAPSE 194 0.0114
367 ORGANISING PNEUMONIA 56 0.0113
368 NEUTROPENIA 1530 0.0112
369 LEFT VENTRICULAR HYPERTROPHY 48 0.0112
370 ASPARTATE AMINOTRANSFERASE INCREASED 595 0.0112
371 TRANSPLANT REJECTION 89 0.0111
372 ANGIOPATHY 62 0.0111
373 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 60 0.0110
374 ARTHRITIS INFECTIVE 51 0.0110
375 PERITONITIS 227 0.0109
376 HYPOTENSION 2198 0.0109
377 VENOUS THROMBOSIS 43 0.0109
378 COVID-19 PNEUMONIA 129 0.0109
379 HEPATOTOXICITY 243 0.0109
380 CARDIAC ARREST 901 0.0109
381 ACUTE MYELOID LEUKAEMIA 169 0.0108
382 HEPATIC ENCEPHALOPATHY 101 0.0108
383 POSTOPERATIVE WOUND INFECTION 73 0.0108
384 ILEUS 134 0.0108
385 LEFT VENTRICULAR DYSFUNCTION 72 0.0107
386 UNRESPONSIVE TO STIMULI 276 0.0107
387 ACUTE PULMONARY OEDEMA 60 0.0107
388 CEREBRAL ISCHAEMIA 55 0.0107
389 BUNDLE BRANCH BLOCK RIGHT 49 0.0107
390 TACHYCARDIA 948 0.0107
391 CYSTIC FIBROSIS 59 0.0106
392 VENTRICULAR FIBRILLATION 118 0.0106
393 PERIORBITAL OEDEMA 55 0.0106
394 THERAPY NON-RESPONDER 475 0.0106
395 RETINAL HAEMORRHAGE 75 0.0105
396 MENINGITIS ASEPTIC 47 0.0105
397 RASH ERYTHEMATOUS 500 0.0104
398 HYPERKALAEMIA 366 0.0104
399 CARDIOMEGALY 128 0.0104
400 INJURY 731 0.0104
401 TREATMENT FAILURE 858 0.0103
402 CHOLANGITIS 64 0.0103
403 TRICUSPID VALVE INCOMPETENCE 82 0.0103
404 LARGE INTESTINE PERFORATION 71 0.0102
405 ELECTROCARDIOGRAM QT PROLONGED 362 0.0101
406 SUBCUTANEOUS ABSCESS 48 0.0100
407 COLITIS 376 0.0099
408 RALES 57 0.0098
409 VASCULITIS 114 0.0098
410 ANAPHYLACTIC SHOCK 252 0.0098
411 LACTIC ACIDOSIS 315 0.0097
412 JOINT EFFUSION 67 0.0097
413 POST PROCEDURAL INFECTION 79 0.0097
414 LIVER INJURY 237 0.0096
415 HEPATIC CYTOLYSIS 123 0.0096
416 NEUROLOGICAL SYMPTOM 55 0.0096
417 HYPOVOLAEMIC SHOCK 46 0.0096
418 GLOMERULAR FILTRATION RATE DECREASED 118 0.0096
419 WHITE BLOOD CELL COUNT INCREASED 368 0.0096
420 RASH GENERALISED 248 0.0096
421 FUNGAL INFECTION 319 0.0096
422 LOW BIRTH WEIGHT BABY 76 0.0096
423 HEPATITIS 244 0.0095
424 CARDIAC MURMUR 82 0.0095
425 UROSEPSIS 87 0.0094
426 BREATH SOUNDS ABNORMAL 46 0.0093
427 CARDIO-RESPIRATORY ARREST 390 0.0093
428 CHRONIC KIDNEY DISEASE 708 0.0093
429 WOUND INFECTION 102 0.0093
430 RASH VESICULAR 45 0.0093
431 ATRIAL FLUTTER 74 0.0093
432 MYOPATHY 80 0.0093
433 HEPATIC LESION 40 0.0092
434 PULMONARY OEDEMA 414 0.0092
435 PERITONITIS BACTERIAL 93 0.0092
436 TROPONIN INCREASED 70 0.0092
437 ECCHYMOSIS 63 0.0092
438 DIVERTICULUM INTESTINAL 40 0.0091
439 SPLENOMEGALY 107 0.0091
440 RESPIRATORY RATE INCREASED 81 0.0091
441 SUSPECTED OFF LABEL USE 41 0.0091
442 LYMPHOPENIA 128 0.0090
443 FOETAL GROWTH RESTRICTION 55 0.0090
444 APNOEA 70 0.0090
445 SUPRAVENTRICULAR TACHYCARDIA 86 0.0090
446 GENERALISED ERYTHEMA 51 0.0090
447 GANGRENE 54 0.0090
448 NONSPECIFIC REACTION 49 0.0089
449 EMBOLISM 74 0.0089
450 INTERNATIONAL NORMALISED RATIO INCREASED 253 0.0089
451 PERICARDIAL EFFUSION 204 0.0088
452 BLOOD CREATINE PHOSPHOKINASE INCREASED 254 0.0088
453 CHOLECYSTITIS 105 0.0088
454 PAPULE 62 0.0088
455 COLITIS ISCHAEMIC 59 0.0087
456 LIPASE INCREASED 67 0.0087
457 DRUG INTERACTION 1383 0.0087
458 PROCTALGIA 56 0.0087
459 VENTRICULAR EXTRASYSTOLES 90 0.0087
460 ORAL CANDIDIASIS 114 0.0086
461 HAEMATOCRIT DECREASED 170 0.0086
462 ODYNOPHAGIA 51 0.0085
463 INFUSION SITE EXTRAVASATION 53 0.0085
464 PNEUMONITIS 231 0.0085
465 CHOLECYSTITIS ACUTE 48 0.0085
466 ALTERED STATE OF CONSCIOUSNESS 183 0.0084
467 SUBARACHNOID HAEMORRHAGE 86 0.0084
468 GRANULOCYTOPENIA 48 0.0084
469 PLEURISY 50 0.0084
470 CARDIAC TAMPONADE 40 0.0084
471 RHABDOMYOLYSIS 350 0.0084
472 IMMUNOSUPPRESSION 74 0.0084
473 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 43 0.0084
474 RENAL CYST 66 0.0083
475 JAUNDICE 223 0.0083
476 NEUTROPHILIA 47 0.0083
477 ABDOMINAL TENDERNESS 41 0.0082
478 UNEVALUABLE EVENT 621 0.0082
479 HYPOTHERMIA 83 0.0082
480 BODY TEMPERATURE INCREASED 167 0.0082
481 MOUTH HAEMORRHAGE 60 0.0082
482 SINUS BRADYCARDIA 79 0.0082
483 PERIPHERAL VASCULAR DISORDER 42 0.0081
484 HYPOCALCAEMIA 154 0.0081
485 REFUSAL OF TREATMENT BY PATIENT 53 0.0081
486 PULMONARY HYPERTENSION 169 0.0081
487 HAEMOPTYSIS 226 0.0081
488 SPINAL OSTEOARTHRITIS 71 0.0081
489 LYMPHADENOPATHY 286 0.0081
490 HYPOGAMMAGLOBULINAEMIA 53 0.0081
491 CARDIAC VALVE DISEASE 46 0.0080
492 PLATELET COUNT DECREASED 857 0.0080
493 HAEMORRHAGE INTRACRANIAL 120 0.0080
494 NEUTROPHIL COUNT DECREASED 327 0.0080
495 HYDRONEPHROSIS 60 0.0080
496 FISTULA 90 0.0080
497 TRANSFUSION 83 0.0079
498 PATHOLOGICAL FRACTURE 40 0.0079
499 DIVERTICULUM 56 0.0079
500 ECONOMIC PROBLEM 119 0.0078
501 CARDIOMYOPATHY 116 0.0078
502 CYTOPENIA 96 0.0078
503 EMPHYSEMA 79 0.0078
504 DELIRIUM 271 0.0078
505 PNEUMONIA ASPIRATION 195 0.0078
506 UPPER GASTROINTESTINAL HAEMORRHAGE 130 0.0077
507 HEPATITIS ACUTE 50 0.0077
508 HYPONATRAEMIA 433 0.0077
509 COMPRESSION FRACTURE 41 0.0076
510 ORAL DISORDER 56 0.0076
511 SKIN LESION 209 0.0076
512 NO THERAPEUTIC RESPONSE 92 0.0075
513 UVEITIS 102 0.0075
514 OESOPHAGITIS 82 0.0075
515 POST PROCEDURAL COMPLICATION 144 0.0075
516 GENERALISED TONIC-CLONIC SEIZURE 124 0.0075
517 PROTEINURIA 142 0.0075
518 ARTERIOSCLEROSIS 70 0.0074
519 INTRACRANIAL PRESSURE INCREASED 41 0.0074
520 CONDITION AGGRAVATED 2234 0.0073
521 RIGHT VENTRICULAR FAILURE 51 0.0073
522 MELAENA 160 0.0073
523 ANAEMIA 1385 0.0073
524 HYPERCALCAEMIA 88 0.0071
525 CYANOSIS 112 0.0071
526 ATRIAL FIBRILLATION 693 0.0071
527 BLOOD CALCIUM DECREASED 80 0.0071
528 SKIN PLAQUE 60 0.0071
529 RIB FRACTURE 146 0.0071
530 DIARRHOEA HAEMORRHAGIC 66 0.0071
531 CARDIAC FAILURE ACUTE 47 0.0070
532 PNEUMONIA 2259 0.0070
533 BRADYCARDIA 370 0.0070
534 POLYURIA 57 0.0070
535 WRONG PRODUCT ADMINISTERED 47 0.0069
536 LUNG INFECTION 108 0.0069
537 GASTROINTESTINAL HAEMORRHAGE 580 0.0069
538 MYOSITIS 62 0.0069
539 TENDERNESS 72 0.0069
540 STRESS CARDIOMYOPATHY 40 0.0069
541 PLATELET COUNT INCREASED 89 0.0068
542 LIVER FUNCTION TEST ABNORMAL 198 0.0068
543 DUODENAL ULCER 48 0.0068
544 NERVOUS SYSTEM DISORDER 212 0.0068
545 RESPIRATORY SYNCYTIAL VIRUS INFECTION 59 0.0068
546 DRUG TOXICITY 92 0.0067
547 CEREBRAL INFARCTION 165 0.0067
548 DIFFUSE LARGE B-CELL LYMPHOMA 52 0.0067
549 ACUTE MYOCARDIAL INFARCTION 199 0.0067
550 NEUTROPHIL COUNT INCREASED 69 0.0067
551 OXYGEN SATURATION DECREASED 378 0.0067
552 PANCREATITIS ACUTE 151 0.0067
553 OEDEMA 364 0.0067
554 EJECTION FRACTION DECREASED 104 0.0067
555 HAEMATURIA 229 0.0067
556 INFECTION 961 0.0066
557 MYOCARDITIS 76 0.0066
558 LIVER DISORDER 294 0.0066
559 GASTROENTERITIS 96 0.0066
560 ASPIRATION 72 0.0066
561 ENTERITIS 42 0.0066
562 DEPRESSED LEVEL OF CONSCIOUSNESS 259 0.0065
563 SMALL INTESTINAL OBSTRUCTION 80 0.0065
564 HAEMATOMA 168 0.0065
565 INTESTINAL PERFORATION 72 0.0064
566 LYMPHOCYTE COUNT DECREASED 113 0.0064
567 PULMONARY TOXICITY 45 0.0064
568 PYELONEPHRITIS 55 0.0063
569 PREMATURE BABY 190 0.0063
570 LIQUID PRODUCT PHYSICAL ISSUE 46 0.0063
571 GENERAL PHYSICAL HEALTH DETERIORATION 728 0.0063
572 INTRAOCULAR PRESSURE INCREASED 80 0.0063
573 BLOOD POTASSIUM DECREASED 188 0.0062
574 INFUSION RELATED REACTION 413 0.0062
575 DISEASE PROGRESSION 736 0.0062
576 HAEMOGLOBIN DECREASED 635 0.0062
577 POLYNEUROPATHY 74 0.0062
578 NERVE COMPRESSION 57 0.0062
579 ELECTROCARDIOGRAM ABNORMAL 48 0.0061
580 PULMONARY CONGESTION 80 0.0061
581 RASH PRURITIC 327 0.0060
582 WHITE BLOOD CELL COUNT DECREASED 653 0.0060
583 BLOOD SODIUM DECREASED 113 0.0060
584 PREMATURE DELIVERY 95 0.0060
585 BLISTER 335 0.0060
586 INTERVERTEBRAL DISC DEGENERATION 55 0.0059
587 MOUTH ULCERATION 125 0.0059
588 BLOOD MAGNESIUM DECREASED 51 0.0059
589 ATAXIA 70 0.0059
590 RESPIRATORY DEPRESSION 72 0.0059
591 OSTEOPENIA 89 0.0059
592 HYPERLIPIDAEMIA 70 0.0059
593 BLOOD POTASSIUM INCREASED 95 0.0058
594 POST PROCEDURAL HAEMORRHAGE 68 0.0058
595 HYPOPHAGIA 149 0.0058
596 BLOOD PRESSURE DIASTOLIC DECREASED 43 0.0058
597 LOWER GASTROINTESTINAL HAEMORRHAGE 43 0.0058
598 DEEP VEIN THROMBOSIS 376 0.0058
599 COMA 275 0.0058
600 HYPOTONIA 57 0.0057
601 CHILLS 668 0.0057
602 DRUG INEFFECTIVE 7459 0.0057
603 SKIN ULCER 145 0.0056
604 RENAL DISORDER 260 0.0056
605 INFUSION SITE ERYTHEMA 47 0.0056
606 NEUROLEPTIC MALIGNANT SYNDROME 66 0.0056
607 PSYCHIATRIC SYMPTOM 41 0.0055
608 PALLOR 151 0.0055
609 LIVER FUNCTION TEST INCREASED 119 0.0055
610 PULMONARY MASS 82 0.0055
611 OFF LABEL USE 4820 0.0055
612 EYE INFLAMMATION 52 0.0054
613 LETHARGY 312 0.0054
614 CARDIAC FAILURE 433 0.0054
615 BRAIN INJURY 54 0.0054
616 HYPERGLYCAEMIA 195 0.0053
617 PROCEDURAL COMPLICATION 41 0.0053
618 BLOOD PRESSURE DECREASED 355 0.0053
619 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 47 0.0053
620 ANGIOEDEMA 235 0.0053
621 DERMATITIS 111 0.0053
622 CEREBRAL HAEMORRHAGE 189 0.0053
623 ABNORMAL FAECES 43 0.0052
624 APPENDICITIS 49 0.0052
625 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 89 0.0052
626 OBSTRUCTIVE AIRWAYS DISORDER 58 0.0052
627 RASH MACULAR 182 0.0052
628 GRAND MAL CONVULSION 48 0.0052
629 DISEASE RECURRENCE 246 0.0052
630 EYELID OEDEMA 60 0.0052
631 CARDIOTOXICITY 46 0.0052
632 RASH 2222 0.0051
633 ERYTHEMA 1047 0.0051
634 HAEMATEMESIS 129 0.0051
635 TOXICITY TO VARIOUS AGENTS 854 0.0051
636 SPUTUM DISCOLOURED 48 0.0051
637 RESPIRATORY DISORDER 151 0.0050
638 EMOTIONAL DISTRESS 611 0.0050
639 FLANK PAIN 47 0.0050
640 OEDEMA PERIPHERAL 610 0.0050
641 DISORIENTATION 198 0.0050
642 HAEMATOCHEZIA 275 0.0050
643 WEIGHT FLUCTUATION 52 0.0050
644 HEPATIC ENZYME INCREASED 333 0.0049
645 VISUAL ACUITY REDUCED 162 0.0049
646 INTERSTITIAL LUNG DISEASE 235 0.0048
647 HALLUCINATION, VISUAL 102 0.0048
648 DEAFNESS 126 0.0048
649 SKIN HYPERPIGMENTATION 41 0.0048
650 DERMATITIS ALLERGIC 60 0.0048
651 SUBDURAL HAEMATOMA 68 0.0047
652 INCONTINENCE 50 0.0047
653 HAEMORRHOIDS 92 0.0047
654 WHEEZING 279 0.0047
655 PRODUCT ADMINISTRATION ERROR 95 0.0047
656 CHOLELITHIASIS 154 0.0047
657 PRODUCT USE IN UNAPPROVED INDICATION 1163 0.0047
658 LEUKAEMIA 44 0.0047
659 ORAL HERPES 91 0.0047
660 INTERVERTEBRAL DISC PROTRUSION 101 0.0046
661 DEFORMITY 43 0.0046
662 PERICARDITIS 77 0.0046
663 HYPOKINESIA 66 0.0045
664 EPILEPSY 138 0.0045
665 HEPATIC STEATOSIS 84 0.0045
666 MYOCARDIAL ISCHAEMIA 51 0.0045
667 RED BLOOD CELL COUNT DECREASED 128 0.0045
668 LOCALISED INFECTION 108 0.0045
669 URINARY TRACT INFECTION 761 0.0045
670 INFLAMMATION 230 0.0045
671 RED BLOOD CELL SEDIMENTATION RATE INCREASED 49 0.0044
672 CONFUSIONAL STATE 714 0.0044
673 GASTRITIS 116 0.0044
674 HIATUS HERNIA 57 0.0044
675 ABDOMINAL PAIN 1023 0.0044
676 DEHYDRATION 585 0.0044
677 COLITIS ULCERATIVE 196 0.0044
678 HYPOGLYCAEMIA 212 0.0044
679 IMPAIRED HEALING 143 0.0044
680 HEMIPARESIS 73 0.0043
681 APHASIA 130 0.0043
682 RESPIRATORY ARREST 118 0.0043
683 ULCER 68 0.0043
684 PHARYNGITIS 53 0.0043
685 SKIN REACTION 60 0.0043
686 FREQUENT BOWEL MOVEMENTS 115 0.0043
687 JOINT RANGE OF MOTION DECREASED 57 0.0042
688 MYELOSUPPRESSION 153 0.0042
689 EXPOSURE DURING PREGNANCY 264 0.0042
690 PULMONARY EMBOLISM 403 0.0042
691 VITAMIN D DEFICIENCY 41 0.0042
692 RASH PAPULAR 94 0.0042
693 SKIN INFECTION 47 0.0042
694 SKIN EXFOLIATION 353 0.0042
695 IMMUNODEFICIENCY 62 0.0042
696 MASS 58 0.0041
697 SCAR 71 0.0041
698 LIP SWELLING 138 0.0041
699 MUSCULOSKELETAL CHEST PAIN 64 0.0041
700 HYPERTENSIVE CRISIS 46 0.0041
701 CARDIAC FAILURE CONGESTIVE 331 0.0041
702 RECTAL HAEMORRHAGE 177 0.0041
703 URTICARIA 689 0.0041
704 STOMATITIS 249 0.0041
705 IMPAIRED QUALITY OF LIFE 59 0.0041
706 PRODUCT PRESCRIBING ISSUE 89 0.0041
707 LUNG DISORDER 200 0.0041
708 LYMPHOMA 63 0.0041
709 PANCREATITIS 215 0.0041
710 THERAPY PARTIAL RESPONDER 63 0.0040
711 INFUSION SITE PAIN 52 0.0040
712 CHROMATURIA 91 0.0040
713 ANXIETY 1147 0.0040
714 RESPIRATORY TRACT CONGESTION 64 0.0040
715 DYSPHAGIA 381 0.0040
716 HEART RATE INCREASED 396 0.0040
717 PAIN IN JAW 113 0.0040
718 REBOUND EFFECT 45 0.0040
719 WOUND 111 0.0040
720 POOR VENOUS ACCESS 41 0.0040
721 DIVERTICULITIS 109 0.0039
722 MUSCLE RIGIDITY 47 0.0039
723 INJECTION SITE EXTRAVASATION 48 0.0039
724 EPISTAXIS 290 0.0039
725 VIRAL INFECTION 129 0.0039
726 CONVULSION 219 0.0038
727 AGITATION 279 0.0038
728 OSTEONECROSIS OF JAW 94 0.0038
729 TOOTH INFECTION 50 0.0038
730 ARRHYTHMIA 179 0.0038
731 DIARRHOEA 2420 0.0037
732 HEPATIC CIRRHOSIS 70 0.0037
733 HYPERSENSITIVITY 690 0.0037
734 PRODUCTIVE COUGH 177 0.0037
735 DENTAL CARIES 41 0.0037
736 DYSARTHRIA 139 0.0037
737 BONE DISORDER 67 0.0037
738 MYELODYSPLASTIC SYNDROME 53 0.0037
739 GLAUCOMA 70 0.0036
740 NEUROPATHY PERIPHERAL 345 0.0036
741 TREATMENT NONCOMPLIANCE 198 0.0036
742 CONJUNCTIVITIS 66 0.0036
743 GASTRIC ULCER 67 0.0035
744 SEIZURE 406 0.0035
745 MATERNAL EXPOSURE DURING PREGNANCY 313 0.0035
746 LOWER RESPIRATORY TRACT INFECTION 159 0.0035
747 RESPIRATORY TRACT INFECTION 91 0.0035
748 PRURITUS 1340 0.0035
749 HERPES ZOSTER 199 0.0035
750 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 245 0.0034
751 PULMONARY FIBROSIS 65 0.0034
752 SKIN DISORDER 113 0.0034
753 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 176 0.0034
754 UPPER RESPIRATORY TRACT INFECTION 154 0.0033
755 BLOOD PRESSURE SYSTOLIC INCREASED 65 0.0033
756 DYSPNOEA 1884 0.0033
757 ABDOMINAL DISTENSION 345 0.0033
758 HYPERTENSION 699 0.0033
759 DYSPNOEA EXERTIONAL 124 0.0033
760 PARALYSIS 47 0.0033
761 OSTEOPOROSIS 135 0.0033
762 HAEMORRHAGE 343 0.0033
763 EYE PAIN 185 0.0033
764 OSTEOARTHRITIS 139 0.0033
765 FAECES DISCOLOURED 71 0.0033
766 SWELLING FACE 212 0.0033
767 ISCHAEMIC STROKE 58 0.0032
768 URINARY RETENTION 108 0.0032
769 TENDONITIS 50 0.0032
770 ORAL PAIN 72 0.0032
771 CORONARY ARTERY DISEASE 97 0.0032
772 BLINDNESS 130 0.0032
773 SINUS DISORDER 63 0.0032
774 INTENTIONAL PRODUCT USE ISSUE 278 0.0032
775 ADVERSE REACTION 42 0.0032
776 FOETAL EXPOSURE DURING PREGNANCY 257 0.0032
777 KIDNEY INFECTION 62 0.0032
778 VOMITING 1482 0.0031
779 PHOTOPHOBIA 59 0.0031
780 TOOTH LOSS 65 0.0031
781 LABORATORY TEST ABNORMAL 92 0.0031
782 PRURITUS GENERALISED 67 0.0031
783 MEDICATION ERROR 171 0.0031
784 METASTASES TO LIVER 54 0.0031
785 LOCAL SWELLING 53 0.0030
786 HEART RATE IRREGULAR 68 0.0030
787 ANGINA PECTORIS 86 0.0030
788 HYPOTHYROIDISM 94 0.0029
789 BLOOD TRIGLYCERIDES INCREASED 52 0.0029
790 METASTASES TO BONE 48 0.0029
791 HALLUCINATION 217 0.0029
792 NEPHROLITHIASIS 132 0.0029
793 MUSCLE TWITCHING 66 0.0029
794 HYPOACUSIS 123 0.0029
795 HEART RATE DECREASED 100 0.0028
796 FLUSHING 289 0.0028
797 GOUT 51 0.0028
798 GASTROOESOPHAGEAL REFLUX DISEASE 228 0.0028
799 RESTLESSNESS 103 0.0028
800 ORTHOSTATIC HYPOTENSION 49 0.0028
801 MENTAL IMPAIRMENT 68 0.0028
802 SWOLLEN TONGUE 87 0.0028
803 DISABILITY 55 0.0028
804 CHEST PAIN 510 0.0028
805 BLOOD PRESSURE INCREASED 416 0.0027
806 ACCIDENTAL OVERDOSE 99 0.0027
807 COUGH 756 0.0027
808 DRUG INTOLERANCE 260 0.0027
809 DYSURIA 99 0.0027
810 SYNCOPE 269 0.0027
811 CYSTITIS 85 0.0027
812 ASTHENIA 1003 0.0027
813 URINARY INCONTINENCE 79 0.0027
814 BONE LOSS 40 0.0027
815 PAIN 1624 0.0026
816 EAR INFECTION 70 0.0026
817 SINUSITIS 269 0.0026
818 GASTROINTESTINAL DISORDER 235 0.0026
819 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 126 0.0026
820 TOOTHACHE 47 0.0026
821 THERAPEUTIC RESPONSE DECREASED 157 0.0026
822 PRODUCT DISPENSING ERROR 56 0.0026
823 PLASMA CELL MYELOMA 100 0.0026
824 WEIGHT DECREASED 709 0.0025
825 OSTEONECROSIS 83 0.0025
826 PRESCRIBED OVERDOSE 48 0.0025
827 THROAT TIGHTNESS 67 0.0025
828 NEURALGIA 60 0.0025
829 INTESTINAL OBSTRUCTION 93 0.0025
830 TYPE 2 DIABETES MELLITUS 83 0.0025
831 INCREASED APPETITE 47 0.0025
832 BLOOD PRESSURE FLUCTUATION 59 0.0025
833 BACK PAIN 566 0.0024
834 LOSS OF CONSCIOUSNESS 312 0.0024
835 PRODUCT USE ISSUE 457 0.0024
836 MALIGNANT NEOPLASM PROGRESSION 248 0.0024
837 BRONCHITIS 179 0.0024
838 AGGRESSION 120 0.0024
839 SWELLING 224 0.0024
840 DECREASED APPETITE 550 0.0024
841 INFLUENZA 263 0.0024
842 DEPRESSION 535 0.0023
843 SKIN DISCOLOURATION 108 0.0023
844 TREMOR 388 0.0023
845 EAR PAIN 45 0.0023
846 COVID-19 406 0.0023
847 SLEEP APNOEA SYNDROME 44 0.0023
848 HYPERHIDROSIS 296 0.0023
849 SEDATION 60 0.0023
850 OROPHARYNGEAL PAIN 212 0.0023
851 NAUSEA 1805 0.0023
852 UPPER LIMB FRACTURE 45 0.0023
853 FLATULENCE 128 0.0023
854 ILLNESS 232 0.0022
855 RETCHING 48 0.0022
856 GALLBLADDER DISORDER 40 0.0022
857 TINNITUS 102 0.0022
858 ASTHMA 249 0.0022
859 DIABETES MELLITUS INADEQUATE CONTROL 39 0.0022
860 LIMB DISCOMFORT 68 0.0022
861 FEELING HOT 134 0.0022
862 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 50 0.0021
863 DIABETES MELLITUS 162 0.0021
864 FEEDING DISORDER 43 0.0021
865 SOMNOLENCE 426 0.0021
866 FOOT FRACTURE 40 0.0021
867 BONE DENSITY DECREASED 66 0.0021
868 THROMBOSIS 167 0.0021
869 ECZEMA 108 0.0021
870 BLOOD PRESSURE ABNORMAL 41 0.0021
871 SPEECH DISORDER 107 0.0020
872 NASAL CONGESTION 120 0.0020
873 PALPITATIONS 239 0.0020
874 DIABETIC KETOACIDOSIS 49 0.0020
875 JOINT STIFFNESS 53 0.0020
876 SYSTEMIC LUPUS ERYTHEMATOSUS 71 0.0020
877 CHEST DISCOMFORT 204 0.0020
878 FLUID RETENTION 101 0.0020
879 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 58 0.0020
880 MUSCULAR WEAKNESS 224 0.0020
881 CEREBROVASCULAR ACCIDENT 333 0.0020
882 PERIPHERAL SWELLING 302 0.0020
883 BURNING SENSATION 136 0.0019
884 PRESYNCOPE 47 0.0019
885 NECK PAIN 108 0.0019
886 MUSCULOSKELETAL PAIN 101 0.0019
887 NIGHT SWEATS 62 0.0019
888 RHINORRHOEA 122 0.0019
889 PROCEDURAL PAIN 52 0.0019
890 DEMENTIA 52 0.0019
891 DRUG ADMINISTRATION ERROR 57 0.0019
892 DYSKINESIA 75 0.0018
893 CONTUSION 177 0.0018
894 ADVERSE DRUG REACTION 165 0.0018
895 DISCOMFORT 112 0.0018
896 MYALGIA 312 0.0018
897 MALAISE 785 0.0018
898 MYOCARDIAL INFARCTION 306 0.0018
899 NEOPLASM PROGRESSION 60 0.0017
900 WEIGHT INCREASED 381 0.0017
901 ABDOMINAL PAIN LOWER 43 0.0017
902 ABASIA 42 0.0017
903 LIMB INJURY 46 0.0017
904 CONSTIPATION 367 0.0017
905 MENTAL DISORDER 73 0.0017
906 AMNESIA 108 0.0017
907 DEATH 1430 0.0017
908 BONE PAIN 97 0.0017
909 FALL 547 0.0016
910 JOINT SWELLING 197 0.0016
911 PARAESTHESIA 256 0.0016
912 OCULAR HYPERAEMIA 77 0.0016
913 PAIN IN EXTREMITY 477 0.0016
914 DYSSTASIA 47 0.0016
915 THERAPY CESSATION 81 0.0016
916 DYSPHONIA 92 0.0016
917 ARTHRITIS 123 0.0016
918 GAIT DISTURBANCE 298 0.0016
919 MOBILITY DECREASED 111 0.0015
920 ABDOMINAL PAIN UPPER 318 0.0015
921 EYE SWELLING 57 0.0015
922 VERTIGO 93 0.0015
923 TRANSIENT ISCHAEMIC ATTACK 51 0.0015
924 HYPOAESTHESIA 223 0.0015
925 COGNITIVE DISORDER 69 0.0015
926 CARDIAC DISORDER 138 0.0015
927 OVERDOSE 312 0.0014
928 VISUAL IMPAIRMENT 179 0.0014
929 HEAD INJURY 45 0.0014
930 FATIGUE 1102 0.0014
931 HIP FRACTURE 45 0.0014
932 HOSPITALISATION 214 0.0014
933 PSYCHOTIC DISORDER 40 0.0014
934 ARTHRALGIA 558 0.0013
935 EYE DISORDER 44 0.0013
936 DISTURBANCE IN ATTENTION 72 0.0013
937 HEADACHE 837 0.0013
938 NASOPHARYNGITIS 246 0.0013
939 IRRITABILITY 80 0.0013
940 CATARACT 79 0.0013
941 POLLAKIURIA 55 0.0013
942 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 237 0.0013
943 DYSPEPSIA 128 0.0013
944 THROAT IRRITATION 58 0.0013
945 CONTRAINDICATED PRODUCT ADMINISTERED 39 0.0013
946 NERVOUSNESS 66 0.0013
947 FEMUR FRACTURE 39 0.0013
948 BLOOD GLUCOSE DECREASED 60 0.0012
949 DIZZINESS 622 0.0012
950 INCORRECT ROUTE OF DRUG ADMINISTRATION 44 0.0012
951 BALANCE DISORDER 106 0.0012
952 ABDOMINAL DISCOMFORT 205 0.0012
953 ILL-DEFINED DISORDER 74 0.0012
954 SURGERY 71 0.0012
955 DRY EYE 60 0.0012
956 MUSCULOSKELETAL STIFFNESS 105 0.0012
957 ROAD TRAFFIC ACCIDENT 49 0.0012
958 NO ADVERSE EVENT 211 0.0012
959 ABNORMAL BEHAVIOUR 46 0.0012
960 VISION BLURRED 156 0.0011
961 MIGRAINE 107 0.0011
962 INFLUENZA LIKE ILLNESS 92 0.0011
963 INSOMNIA 297 0.0011
964 DYSGEUSIA 81 0.0011
965 SLEEP DISORDER 76 0.0011
966 BLOOD GLUCOSE INCREASED 198 0.0010
967 INTENTIONAL PRODUCT MISUSE 90 0.0010
968 MUSCLE SPASMS 185 0.0010
969 ARTHROPATHY 55 0.0010
970 INCORRECT DOSE ADMINISTERED 221 0.0010
971 DRY MOUTH 76 0.0009
972 RHEUMATOID ARTHRITIS 106 0.0009
973 ALOPECIA 170 0.0009
974 DRUG EFFECT DECREASED 46 0.0009
975 FEELING ABNORMAL 202 0.0008
976 ADVERSE EVENT 77 0.0008
977 DRUG WITHDRAWAL SYNDROME 73 0.0008
978 MEMORY IMPAIRMENT 112 0.0008
979 THERAPY INTERRUPTED 57 0.0008
980 NEOPLASM MALIGNANT 53 0.0008
981 SUICIDAL IDEATION 71 0.0008
982 PRODUCT DOSE OMISSION ISSUE 207 0.0007
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 46 0.0006
984 HOT FLUSH 48 0.0006
985 DRY SKIN 85 0.0006
986 PRODUCT QUALITY ISSUE 86 0.0006
987 PRODUCT STORAGE ERROR 55 0.0006
988 DEVICE MALFUNCTION 41 0.0006
989 UNDERDOSE 42 0.0006
990 PSORIASIS 60 0.0005
991 INJECTION SITE ERYTHEMA 49 0.0004
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 79 0.0004
993 DRUG DOSE OMISSION 56 0.0003
994 INJECTION SITE PAIN 79 0.0003